Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials
ObjectiveTo systematically evaluate the efficacy and safety of a new hypoglycemic drug, tirzepatide, for treating obesity based on indicators such as BMI, waist circumference, and body weight.MethodsA search formula was written using search terms such as “tirzepatide,” “overweight,” and “obesity.” A...
Main Authors: | Wenting Cai, Ruobin Zhang, Yao Yao, Qiuhui Wu, Jinping Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1277113/full |
Similar Items
-
The effects of subcutaneous Tirzepatide on obesity and overweight: a systematic review and meta‐regression analysis of randomized controlled trials
by: Pejman Rohani, et al.
Published: (2023-08-01) -
The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?
by: Han Na Jung, et al.
Published: (2022-03-01) -
Tirzepatide-induced ketoacidosis in non-diabetic patients
by: Pathan Mohamad Rafe Iqbal, et al.
Published: (2024-03-01) -
Generalizability of the SURPASS‐2 Trial and Effect of Tirzepatide on US Diabetes and Obesity Control
by: Nicholas Chiu, et al.
Published: (2022-08-01) -
Association between High Normal TSH Levels and Obesity in Women with Anti-Thyroid Autoantibodies (ATAs)
by: Fernanda Velluzzi, et al.
Published: (2022-08-01)